Printer-friendly version
Integra® Wound Matrix (Thin) is an advanced wound care device comprised of collagen and glycosaminoglycan that maintains and supports a healing environment for wound management. Integra® Wound Matrix (Thin) contains 50% less collagen than Integra® Wound Matrix.
• Provides immediate wound coverage
• Highly conformable for various anatomic sites
• May be used in conjunction with other secondary dressings
• Room temperature storage
Integra® Wound Matrix (Thin) is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears) and draining wounds. The device is intended for one-time use.
This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. This device is not indicated for use in third-degree burns.
Do not resterilize. Discard all opened and unused portions of the device. Do not use if package seal is broken.
Complications are possible with the use of wound dressings including infection, chronic inflammation, allergic reaction, excessive redness, pain or swelling.
Room temperature with a 24-month shelf life.
| Assigned HCPCS code | |
| Minimally manipulated | |
| Dehydrated | |
| Desiccated | |
| Flowable | |
| Micronized | |
| Sheet form | ● |
| Requires refrigeration | |
| Shelf life greater than 2 years | |
| Shelf life limited | |
| Indicated for acute wounds | ● |
| Indicated for chronic wounds | ● |
| Indicated for diabetic ulcers | ● |
| Indicated for pressure ulcers | ● |
| Indicated for second-degree burns | |
| Indicated for surgical wounds | ● |
| Indicated for third-degree burns | |
| Indicated for venous ulcers | ● |
| Contact manufacturer for usage guidelines |
| Educational Material Available | ● |
| Free Samples/Trials Available | |
| Published Clinical Article Available |
Acute Wounds
Burns
Chronic Wounds
Deep Wounds
Diabetic Foot
Hypertrophic Scars/Keloids
Pressure Ulcers
Surgical Wounds
Venous Ulcers
Always handle Integra® Wound Matrix and Integra® Wound Matrix (Thin) using aseptic technique. Peel open the outer pouch and remove the inner foil pouch. Place foil pouch flat on sterile surface and peel it open. Remove product, including the protective polyethylene sheets. Separate product from the polyethylene sheets by slowly and carefully peeling back from one of the corner edges. Handle with care as product is fragile. Place product into basin containing a sterile saline solution. Rinse the product free of storage buffer by immersion in sterile saline for one to two minutes. Keep product in the basin until application.
Prepare wound bed using standard methods to ensure wound is free of debris and necrotic tissue. If necessary, surgically debride the wound to ensure the wound edges contain viable tissue. Cut the device to size and apply immediately following wound bed preparation. Smooth Integra® Wound Matrix and Integra® Wound Matrix (Thin) into place to ensure the sheet is in contact with the underlying wound bed.
After application, use appropriate secondary dressings to maintain dressing adherence and protect the wound area. The optimum secondary dressing is determined by wound location, size, depth and user preference.
Change the secondary dressing as needed. Frequency of secondary dressing change will be dependent upon volume of exudate produced, type of dressing used and the clinician’s need to inspect the wound bed for signs of infection or healing.
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery and reconstructive and general surgery.